Skip navigation

Senior Oncologist - STORM Therapeutics

12 September 2017

Following the success of our series A financing, we are now looking to recruit a senior oncologist with significant experience in translational oncology to lead Storm’s target validation and disease positioning strategy and manage our external pre-clinical oncology activities.

Working closely with the senior management team, you will be key in defining Storm’s therapeutic area strategy in oncology and shape our growing drug discovery portfolio. This role has a strong external-facing element, providing the main interface for interactions with external experts and contract research organisations.

In this role you will:

  • Define and lead Storm's translational oncology strategy, including the use of pre-clinical in vitro and in vivo models for Storm’s drug discovery programmes
  • Using internal and external pre-clinical and clinical datasets, identify new opportunities for RNA modifying enzymes as targets for cancer drug discovery
  • Work with the VP R&D to define biomarker strategy, clinical development path, therapeutic endpoints and patient stratification strategies for Storm's drug discovery programmes
  • Identify external partners (CROs and academic groups) to access reliable and robust in vitro and in vivo oncology models
  • Lead, co-ordinate and manage Storm’s external pre-clinical activities for all oncology focused research programmes.

STORM Therapeutics offers an industry competitive salary and benefits package.

STORM is backed by blue chip investors Cambridge Innovation Capital, Merck Ventures, Pfizer Ventures and Touchstone Innovations, who share the founders’ ambitions to build a world-leading company in the field. The company occupies modern, well-equipped laboratories on the Babraham Research Campus near Cambridge.

Qualifications and experience required:
  • PhD / MD in cancer biology or a cancer-related discipline
  • 3+ years’ post-doctoral experience; industry experience would be advantageous
  • Significant experience in translational oncology spanning pre-clinical to clinical activities, including the use of cancer cell panels and state-of-the-art in vivo models for drug discovery and development
  • Strong network of external cancer experts, including academic researchers, clinicians and pre-clinical contract research organisations
  • An in-depth understanding of the current and future therapeutic landscape in oncology
  • Experience in using genomic and other -omic datasets, including from pharmacological and CRISPR/siRNA-based genomic screens, to guide drug development, disease positioning and future patient stratification strategies.

In addition, you will be able to demonstrate a track record of achievements and skills such as:
  • High-quality refereed publications
  • Ability to work both independently and as part of a team to deliver research projects to time & budget
  • Excellent inter personal skills and a track record of successful collaboration with immediate colleagues, external partners and across scientific discipline
  • Good presentational skills, both oral and written.

Candidates must be legally entitled to work in the UK. 

To apply:

Contact Dr Oliver Rausch